Buvidal® Weekly and Buvidal® Monthly (CAM2038) Approved in Australia as the First Long-acting Treatment of Opioid Dependence PR Newswire LUND...
Camurus Receives EU Approval for Weekly and Monthly Buvidal® (CAM2038) for Opioid Dependence PR Newswire LUND, Sweden, Nov. 22, 2018 - Buvidal®...
Camurus Receives EU Approval for Weekly and Monthly Buvidal® (CAM2038) for Opioid Dependence - Buvidal® is the first long-acting medicine...
CHMP Recommends Approval of Buvidal® (CAM2038) for the Treatment of Opioid Dependence PR Newswire LUND, Sweden, Sept. 21, 2018 On approval...
CHMP Recommends Approval of Buvidal® (CAM2038) for the Treatment of Opioid Dependence On approval, Buvidal® would be the first long-acting...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.